Diagnostics & Imaging
Delirium Monitoring Solution
AI analysis of point-of-care EEG supporting clinicians in delirium screening and monitoring.
The Signal
Ceribell announced commercial launch November 2, 2026, following FDA 510(k) clearance on December 9, 2025. Seizure and delirium monitoring use the same platform and headband. CMS NTAP is up to $2,171 per eligible Medicare case from October 1, 2026, not a guaranteed payment for every case.
Company profileMore in Diagnostics & Imaging
Aidoc
AI platform that analyzes medical images to flag acute abnormalities for radiologist review.
View toolViz.ai
AI powered care coordination platform that detects strokes and coordinates specialist response.
View toolLunit
AI software analyzing mammography and chest radiographs to detect early signs of cancer.
View toolPaige AI
AI pathology software assisting pathologists in diagnosing prostate and breast cancers from tissue slides.
View tooliRhythm
Continuous cardiac monitoring system utilizing wearable sensors and deep learning to detect arrhythmias.
View toolPathAI
AI powered pathology platform assisting researchers with precise tissue analysis and clinical trials.
View tool